News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
420,273 Results
Type
Article (30200)
Company Profile (108)
Press Release (389965)
Section
Business (105869)
Career Advice (540)
Deals (18636)
Drug Delivery (87)
Drug Development (51636)
Employer Resources (80)
FDA (11536)
Job Trends (10359)
News (192436)
Policy (22068)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
Academia (2151)
Academic (2)
Accelerated approval (5)
Adcomms (22)
Allergies (60)
Alliances (29232)
ALS (59)
Alzheimer's disease (1045)
Antibody-drug conjugate (ADC) (65)
Approvals (11571)
Artificial intelligence (195)
Autoimmune disease (10)
Automation (7)
Bankruptcy (158)
Best Places to Work (9278)
BIOSECURE Act (8)
Biosimilars (83)
Biotechnology (60)
Bladder cancer (49)
Brain cancer (12)
Breast cancer (166)
Cancer (1269)
Cardiovascular disease (143)
Career advice (494)
Career pathing (9)
CAR-T (64)
Cell therapy (219)
Cervical cancer (17)
Clinical research (43791)
Collaboration (496)
Compensation (62)
Complete response letters (10)
COVID-19 (2295)
CRISPR (24)
C-suite (127)
Cystic fibrosis (66)
Data (1409)
Decentralized trials (2)
Denatured (15)
Depression (38)
Diabetes (192)
Diagnostics (4917)
Digital health (17)
Diversity (6)
Diversity, equity & inclusion (23)
Drug discovery (73)
Drug pricing (100)
Drug shortages (10)
Duchenne muscular dystrophy (64)
Earnings (36633)
Editorial (25)
Employer branding (8)
Employer resources (71)
Events (74793)
Executive appointments (457)
FDA (12402)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (515)
Gene editing (50)
Generative AI (21)
Gene therapy (172)
GLP-1 (483)
Government (4283)
Grass and pollen (3)
Guidances (38)
Healthcare (15316)
Huntington's disease (17)
IgA nephropathy (21)
Immunology and inflammation (62)
Indications (17)
Infectious disease (2420)
Inflammatory bowel disease (99)
Inflation Reduction Act (10)
Influenza (47)
Intellectual property (42)
Interviews (58)
IPO (8090)
IRA (38)
Job creations (1511)
Job search strategy (449)
Kidney cancer (7)
Labor market (10)
Layoffs (235)
Leadership (4)
Legal (3996)
Liver cancer (55)
Lung cancer (207)
Lymphoma (77)
Machine learning (4)
Management (30)
Manufacturing (152)
MASH (49)
Medical device (9585)
Medtech (9588)
Mergers & acquisitions (10872)
Metabolic disorders (481)
Multiple sclerosis (58)
NASH (20)
Neurodegenerative disease (67)
Neuropsychiatric disorders (24)
Neuroscience (1417)
NextGen: Class of 2025 (5082)
Non-profit (3949)
Northern California (1551)
Now hiring (6)
Obesity (254)
Opinion (134)
Ovarian cancer (37)
Pain (57)
Pancreatic cancer (37)
Parkinson's disease (93)
Partnered (13)
Patents (100)
Patient recruitment (76)
Peanut (36)
People (33004)
Pharmaceutical (32)
Pharmacy benefit managers (17)
Phase I (11666)
Phase II (18319)
Phase III (16868)
Pipeline (754)
Podcasts (41)
Policy (95)
Postmarket research (1781)
Preclinical (3417)
Press Release (49)
Prostate cancer (65)
Psychedelics (25)
Radiopharmaceuticals (153)
Rare diseases (268)
Real estate (2882)
Recruiting (32)
Regulatory (15344)
Reports (21)
Research institute (1944)
Resumes & cover letters (40)
Rett syndrome (3)
RNA editing (3)
RSV (35)
Schizophrenia (61)
Series A (86)
Series B (61)
Service/supplier (4)
Sickle cell disease (49)
Southern California (1291)
Special edition (9)
Spinal muscular atrophy (107)
Sponsored (18)
Startups (2129)
Stomach cancer (6)
Supply chain (44)
Tariffs (7)
The Weekly (25)
United States (14435)
Vaccines (570)
Venture capitalists (22)
Webinars (8)
Weight loss (154)
Women's health (33)
Worklife (6)
Date
Today (78)
Last 7 days (537)
Last 30 days (1852)
Last 365 days (22762)
2025 (5931)
2024 (23574)
2023 (26328)
2022 (35789)
2021 (39255)
2020 (39395)
2019 (34738)
2018 (26061)
2017 (19358)
2016 (20014)
2015 (22890)
2014 (16964)
2013 (13268)
2012 (14045)
2011 (14494)
2010 (12571)
Location
Africa (527)
Alabama (38)
Alaska (6)
Arizona (118)
Arkansas (11)
Asia (23155)
Australia (4185)
California (3473)
Canada (1282)
China (318)
Colorado (172)
Connecticut (199)
Delaware (85)
Europe (51717)
Florida (547)
Georgia (174)
Hawaii (1)
Idaho (35)
Illinois (362)
India (20)
Indiana (275)
Iowa (5)
Japan (111)
Kansas (76)
Kentucky (16)
Louisiana (9)
Maine (65)
Maryland (627)
Massachusetts (2666)
Michigan (144)
Minnesota (227)
Mississippi (2)
Missouri (78)
Montana (16)
Nebraska (20)
Nevada (44)
New Hampshire (52)
New Jersey (1247)
New Mexico (11)
New York (1125)
North Carolina (660)
North Dakota (2)
Northern California (1551)
Ohio (126)
Oklahoma (9)
Oregon (23)
Pennsylvania (874)
Puerto Rico (5)
Rhode Island (15)
South America (682)
South Carolina (12)
South Dakota (1)
Southern California (1291)
Tennessee (81)
Texas (481)
Utah (144)
Virginia (83)
Washington D.C. (44)
Washington State (390)
West Virginia (3)
Wisconsin (44)
420,273 Results for "endpoint health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BREAKING: Dermata’s XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints
March 28, 2025
·
8 min read
Press Releases
Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients
March 10, 2025
·
9 min read
Press Releases
Transcend Therapeutics Announces Primary Endpoint Met in IMPACT-1 Phase 2 Study of TSND-201 in PTSD
March 31, 2025
·
1 min read
Press Releases
Emalex Biosciences’ Lead Candidate Meets Primary and Secondary Endpoints in Phase 3 Tourette Syndrome Study
February 25, 2025
·
4 min read
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Press Releases
Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
April 2, 2025
·
9 min read
Press Releases
Oryzon Defines Phase III Trial Endpoints for Agitation and Aggression in BPD with Input From New Clinical Advisory Board
March 3, 2025
·
9 min read
Press Releases
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
March 31, 2025
·
6 min read
Press Releases
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
February 10, 2025
·
7 min read
1 of 42,028
Next
